MAN 02
Alternative Names: MAN-02Latest Information Update: 28 Jan 2023
At a glance
- Originator Q BioMed
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Acute kidney injury
Most Recent Events
- 28 Jan 2023 No recent reports of development identified for preclinical development in Acute kidney injury in USA
- 31 Dec 2018 Preclinical trials in Acute kidney injury in USA (unspecified route)